COMMUNIQUÉS West-GlobeNewswire

Atlantic Healthcare completes patient enrollment to its Phase 3 study of alicaforsen to treat IBD Pouchitis
02/05/2018
Study completion and top-line data expected in Q1 2019 CAMBRIDGE, U.K., May 02, 2018 (GLOBE NEWSWIRE) -- Atlantic Healthcare plc (Atlantic Healthcare), an emerging trans-Atlantic pharmaceutical company with a core focus [...]
Ziopharm Oncology to Announce First Quarter 2018 Financial Results, Host Conference Call May 10
02/05/2018
BOSTON, May 02, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq: ZIOP ), today announced that management will host a conference call and webcast slide presentation on Thursday, May 10, at 4:30 p.m. ET to [...]
Insmed Reports First Quarter 2018 Financial Results and Provides Business Update
02/05/2018
Submitted NDA to FDA for Amikacin Liposome Inhalation Suspension (ALIS) in NTM lung disease caused by MAC; anticipates priority review Actively preparing for potential product launch of ALIS in 4Q 2018 BRIDGEWATER, N.J [...]
Neos Therapeutics to Host First Quarter 2018 Financial Results Conference Call on May 9, 2018
02/05/2018
DALLAS and FORT WORTH, Texas, May 02, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ: NEOS ), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) [...]
Marinus Pharmaceuticals Provides Business Update and First Quarter 2018 Financial Results
02/05/2018
RADNOR, Pa., May 02, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS ) (“Marinus” or “Company”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy [...]
Otonomy to Report First Quarter 2018 Financial Results and Provide Corporate Update
02/05/2018
Webcast and Conference Call to be Held at 4:30 p.m. EDT on May 9, 2018 SAN DIEGO, May 02, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC ), a biopharmaceutical company dedicated to the development of innovative [...]
Kura Oncology Announces New Patent for Tipifarnib in Hematologic Malignancies
02/05/2018
– Newly issued patent expands protection for tipifarnib in U.S., provides exclusivity in certain CXCL12-expressing cancers to 2037 – – Second U.S. patent for tipifarnib reinforces potential for broader strategy to [...]
Avadel Pharmaceuticals Reports First Quarter 2018 Results
02/05/2018
NOCTIVA™ launch underway across the U.S. FT 218 granted Orphan Drug Designation Generated revenue of $33.3 million DUBLIN, Ireland, May 02, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ: AVDL ) today [...]
PCI Biotech: Invitation to first quarter 2018 presentation
02/05/2018
Oslo,Norway, 2 May 2018 - PCI Biotech invites to a presentation of the company's first quarter 2018 report on Tuesday 8 May 2018 at Oslo Cancer Cluster Innovation Park. Time: Tuesday May 8, 08:30am - 09:30am CEST (local [...]
Myriad Genetics Named to Forbes 2018 List of America’s Best Midsize Employers
02/05/2018
SALT LAKE CITY, May 02, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics , Inc. (NASDAQ: MYGN ), a leader in molecular diagnostics and personalized medicine, today announced that the company was named to Forbes 2018 list of [...]
Achaogen Stock Trading Halted Today
02/05/2018
-- FDA Advisory Committee to Review Plazomicin for the Treatment of Adults with Complicated Urinary Tract Infections (cUTI) and Bloodstream Infections (BSI) -- SOUTH SAN FRANCISCO, Calif., May 02, 2018 (GLOBE NEWSWIRE [...]
Antares Pharma to Present at the Deutsche Bank Securities, Inc. 43rd Annual Health Care Conference
02/05/2018
EWING, N.J., May 02, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS ) today announced that Robert Apple, President and Chief Executive Officer, will present at the Deutsche Bank Securities, Inc. 43rd Annual [...]
Rapid Micro Biosystems Secures $60 Million In Equity Financing
02/05/2018
Investment to Accelerate Company's Continued Global Commercial Expansion and Product Innovation LOWELL, Mass., May 02, 2018 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, the leading provider of automated, growth-based, [...]
FibroGen to Report First Quarter 2018 Financial Results on Wednesday, May 9, 2018
02/05/2018
Conference Call and Audio Webcast Scheduled for 5:00 p.m. ET (2:00 p.m. PT) SAN FRANCISCO, May 02, 2018 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN ), a science-based biopharmaceutical company, today announced that [...]
Recro Pharma to Report First Quarter 2018 Financial Results and Host Conference Call and Webcast on May 9, 2018
02/05/2018
Conference Call and Webcast Scheduled for Wednesday, May 9, 2018 at 8:00 a.m. ET MALVERN, Pa., May 02, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ: REPH ), a revenue generating specialty pharmaceutical company [...]
Amedisys Closes on Acquisition Expanding Personal Care to Tennessee
02/05/2018
BATON ROUGE, La., May 02, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED ), one of the nation’s leading home healthcare, hospice and personal care companies, announced today that its subsidiary, Associated Home [...]
Akcea Announces Expansion of Global Early Access Program to Provide Volanesorsen to People Living with FCS
02/05/2018
Program currently available in the U.S. and select countries in Europe; initiating additional countries throughout 2018 CAMBRIDGE, Mass., May 02, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA ) today [...]
miRagen Therapeutics to Report First Quarter 2018 Financial Results and Host Conference Call on May 9, 2018
02/05/2018
BOULDER, Colo., May 02, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN ), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, will host a [...]
Solon Eiendom ASA : Primary insider notification
02/05/2018
(Oslo, Norway, May 02, 2018) Solon Eiendom ASA Chairman of the Board Simen Thorsen has today transferred 4,000,000 shares in Solon Eiendom ASA from his wholly owned company Hortulan AS at a price of NOK 25.00 per share [...]

Pages